A number of antineoplastic agents including procarbazine and bisantren
e derive from hydrazine, but so far none have been developed from semi
carbazide. In order to assay active minimal structures, thirteen new c
ompounds were prepared by replacing hydrogen atoms in semicarbazone am
ine group by alkylamine moieties, employing an improved procedure. DNA
binding was evaluated by treatment of a drug solution with DNA-cellul
ose complex and further measurement of remaining drug by UV spectrosco
py and the affinity observed to range from medium to weak. On testing
these compounds against human neoplastic cell lines, only a nitroderiv
ative proved active on CNS and Breast cell lines at 10(-4) M. This mem
ber was studied by cyclic voltammetry.